Lyfegen Raises $8 Million To Drive Down Drug Costs And Help Patients Access Life-Saving Medications
09/20/22, 1:32 PM
Location
new york
Money raised
$8 million
Industry
medical
health care
analytics
Lyfegen, a global healthtech SaaS company driving the world's transition from volume to value-based healthcare for high-cost drugs, today announced an oversubscribed $8 million Series A financing round led by aMoon, with additional participation from APEX Ventures and others.
Company Info
Location
sunset lake road
new york, united states
Additional Info
Lyfegen is an independent, global software analytics company providing a value and outcome-based agreement platform for health insurances, pharma, medtech & hospitals around the globe. The secure platform identifies and operationalizes value-based payment models cost-effectively and at scale using a variety of real-world data and machine learning. With Lyfegen's patent-pending platform, health insurances & hospitals can implement and scale value-based healthcare, improving access to treatments, patient health outcomes and affordability.
Lyfegen is based in the USA & Switzerland, and was founded by individuals with decades of experience in healthcare, pharma and technology to enable the shift away from volume-based and fee-for-service healthcare to value-based healthcare. For more information, visit www.lyfegen.com.
Related Links:https://lyfegen.com/Linkedin: https://www.linkedin.com/company/lyfegenhealth